T.O.R.C.H. Congenital
Infections: Elite
Clinical Mastery Test
Bank
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ Welcome to the Big Leagues
○ The "Critical Action" Cheat Sheet (2026/2027 Standards)
○ Elite T.O.R.C.H. Diagnostic & Pharmacological Matrix
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application: Diagnostic criteria,
pathophysiology, and pharmacological hard decks.
○ Questions 29–58: Professional Simulation: High-stress ward scenarios, labor
and delivery crises, and 2026 state-mandated legal reporting.
○ Questions 59–88: Grandmaster Synthesis: Multi-system matrices requiring the
intersection of pharmacology, maternal-fetal hemodynamics, and NICU protocols.
PART I: THE PRIMER
Welcome to the Big Leagues. This test bank is not designed to help you pass a written
academic exam; it is designed to forge you into an elite maternal-fetal and neonatal practitioner
who does not hesitate when two lives are on the line. By intercepting high-stakes errors here,
you build the lethal professional intuition required to avert catastrophic congenital morbidity on
the ward. We are operating strictly on 2026/2027 clinical protocols.
The "Critical Action" Cheat Sheet
● Syphilis (The Texas Triad): By 2026 law, you must screen at the first prenatal visit, the
third trimester (no earlier than 28 weeks), and at delivery. Treatment must begin 30 days
prior to delivery to prevent congenital transmission.
● Cytomegalovirus (CMV): For primary maternal infection in the first trimester, the 2026
standard is Valacyclovir 8g/day (administered as 2g four times daily to bypass acute renal
failure) until amniocentesis.
● Parvovirus B19: A positive maternal IgM requires immediate tracking of the fetal Middle
Cerebral Artery (MCA) peak systolic velocity every 1 to 2 weeks for 12 weeks to intercept
, lethal fetal anemia.
● Toxoplasmosis: Spiramycin is a prophylactic wall. If amniocentesis PCR is positive (>18
weeks), immediately switch to Pyrimethamine, Sulfadiazine, and Folinic Acid.
● Varicella-Zoster (VZV): Post-exposure Varicella-Zoster Immune Globulin (VZIG) protects
the mother from fatal pneumonia; it does not prevent fetal viremia.
Elite T.O.R.C.H. Diagnostic & Pharmacological Matrix
Pathogen Maternal Fetal Diagnosis 2026 Antenatal Classic Neonatal
Diagnostic Marker (Amnio PCR) Intervention Presentation
Toxoplasmosis IgM+, Low IgG >18 weeks Spiramycin Intracranial
Avidity gestation (Prophylaxis) / calcifications,
Pyrimethamine + chorioretinitis,
Sulfadiazine hydrocephalus
(Treatment)
Rubella IgM+, Low IgG Not routinely None (Prevention Deafness,
Avidity performed via preconception cataracts, PDA,
MMR only) "blueberry muffin"
rash
CMV IgM+, Low IgG >21 weeks & >6 Valacyclovir Periventricular
Avidity weeks 8g/day (2g QID) calcifications,
post-infection sensorineural
hearing loss
HSV Active genital Not routinely C-Section for Vesicular rash,
lesions performed active lesions; temporal lobe
Valacyclovir encephalitis
suppression at 36
wks
Syphilis RPR/VDRL + Fetal ultrasound IM Bicillin L-A Snuffles,
Treponemal (Hydrops/Hepatom (Penicillin G) maculopapular
confirmation egaly) rash,
osteochondritis
Parvovirus B19 IgM+, IgG- MCA Doppler >1.5 Intrauterine blood Severe anemia,
MoM transfusion via nonimmune
cordocentesis hydrops fetalis
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: A 24-year-old at 10 weeks gestation tests positive for primary Cytomegalovirus (CMV).
Which pharmacological intervention is the MOST APPROPRIATE INITIAL action to prevent
vertical transmission? A) Intravenous Ganciclovir. B) CMV Hyperimmune Globulin (HIG) 100
IU/kg. C) Oral Valacyclovir 8g/day. D) Oral Valganciclovir.
● The Answer: C (Oral Valacyclovir 8g/day.)
● Distractor Analysis:
○ A & D are incorrect: Teratogenic; strictly reserved for neonatal or severe adult
, disease.
○ B is incorrect: 2026 ECCI consensus strictly recommends against HIG due to
inefficacy.
The Mentor's Analysis: High-dose Valacyclovir (8g/day) is the 2026 first-trimester paradigm
shift, reducing transmission by 70%. It must be split into 2g QID to prevent acute renal failure.
Professional Intuition: Protect the fetus with the dose; protect the maternal kidneys with the
frequency.
Q2: A neonate born at 38 weeks exhibits chorioretinitis. The mother had a documented
Toxoplasma gondii infection at 22 weeks. Which additional finding is MOST LIKELY present? A)
Periventricular calcifications. B) Diffuse intracranial calcifications. C) Patent ductus arteriosus.
D) Sensorineural hearing loss.
● The Answer: B (Diffuse intracranial calcifications.)
● Distractor Analysis:
○ A is incorrect: Periventricular calcifications are the hallmark of CMV.
○ C & D are incorrect: Classic findings of Congenital Rubella Syndrome.
The Mentor's Analysis: Toxoplasmosis destroys the brain globally, leaving diffuse calcifications
scattered throughout the parenchyma. CMV prefers the ependymal cells, leaving a tight ring
around the ventricles. Professional Intuition: Toxo is scattered; CMV hugs the ventricles.
Q3: Under Texas DSHS 2026 mandates, at which specific gestational juncture is the
third-trimester syphilis screening strictly legally valid? A) At exactly 24 weeks gestation. B) No
earlier than 28 weeks gestation. C) Between 35 and 37 weeks gestation. D) At the onset of
active labor.
● The Answer: B (No earlier than 28 weeks gestation.)
● Distractor Analysis:
○ A is incorrect: Texas law explicitly forbids drawing the third-trimester screen before
28 weeks.
○ C is incorrect: This is the GBS screening window.
○ D is incorrect: Delivery screening is a separate, third mandated test.
The Mentor's Analysis: The 28-week mark is a rigid legal boundary designed to intercept
late-acquired syphilis with enough time (at least 30 days) to treat the mother prior to delivery.
Professional Intuition: Drawing the lab at 27 weeks and 6 days is a critical compliance failure.
Q4: A pregnant patient is exposed to Parvovirus B19. Serology returns: IgG positive, IgM
negative. What is the MOST APPROPRIATE clinical management? A) Initiate serial MCA
Doppler ultrasounds every 2 weeks. B) Administer Varicella-Zoster Immune Globulin (VZIG). C)
Reassure the patient and resume routine prenatal care. D) Schedule an amniocentesis for viral
PCR testing.
● The Answer: C (Reassure the patient and resume routine prenatal care.)
● Distractor Analysis:
○ A & D are incorrect: Invasive or resource-intensive protocols reserved for acute
infections (IgM positive).
○ B is incorrect: VZIG is for Varicella, not Parvovirus.
The Mentor's Analysis: IgG positive with IgM negative indicates remote past exposure and
current absolute immunity. The mother cannot transmit what she cannot catch. Professional
Intuition: Do not chase ghosts. Document immunity and discharge anxiety.
Q5: A G3P2 at 14 weeks gestation presents with acute primary Toxoplasmosis. Which
pharmacological agent is the FIRST-LINE treatment at this gestational age? A) Pyrimethamine.
B) Sulfadiazine. C) Spiramycin. D) Valacyclovir.
● The Answer: C (Spiramycin.)
Infections: Elite
Clinical Mastery Test
Bank
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ Welcome to the Big Leagues
○ The "Critical Action" Cheat Sheet (2026/2027 Standards)
○ Elite T.O.R.C.H. Diagnostic & Pharmacological Matrix
● PART II: THE ELITE TEST BANK
○ Questions 1–28: Foundational Syntax & Application: Diagnostic criteria,
pathophysiology, and pharmacological hard decks.
○ Questions 29–58: Professional Simulation: High-stress ward scenarios, labor
and delivery crises, and 2026 state-mandated legal reporting.
○ Questions 59–88: Grandmaster Synthesis: Multi-system matrices requiring the
intersection of pharmacology, maternal-fetal hemodynamics, and NICU protocols.
PART I: THE PRIMER
Welcome to the Big Leagues. This test bank is not designed to help you pass a written
academic exam; it is designed to forge you into an elite maternal-fetal and neonatal practitioner
who does not hesitate when two lives are on the line. By intercepting high-stakes errors here,
you build the lethal professional intuition required to avert catastrophic congenital morbidity on
the ward. We are operating strictly on 2026/2027 clinical protocols.
The "Critical Action" Cheat Sheet
● Syphilis (The Texas Triad): By 2026 law, you must screen at the first prenatal visit, the
third trimester (no earlier than 28 weeks), and at delivery. Treatment must begin 30 days
prior to delivery to prevent congenital transmission.
● Cytomegalovirus (CMV): For primary maternal infection in the first trimester, the 2026
standard is Valacyclovir 8g/day (administered as 2g four times daily to bypass acute renal
failure) until amniocentesis.
● Parvovirus B19: A positive maternal IgM requires immediate tracking of the fetal Middle
Cerebral Artery (MCA) peak systolic velocity every 1 to 2 weeks for 12 weeks to intercept
, lethal fetal anemia.
● Toxoplasmosis: Spiramycin is a prophylactic wall. If amniocentesis PCR is positive (>18
weeks), immediately switch to Pyrimethamine, Sulfadiazine, and Folinic Acid.
● Varicella-Zoster (VZV): Post-exposure Varicella-Zoster Immune Globulin (VZIG) protects
the mother from fatal pneumonia; it does not prevent fetal viremia.
Elite T.O.R.C.H. Diagnostic & Pharmacological Matrix
Pathogen Maternal Fetal Diagnosis 2026 Antenatal Classic Neonatal
Diagnostic Marker (Amnio PCR) Intervention Presentation
Toxoplasmosis IgM+, Low IgG >18 weeks Spiramycin Intracranial
Avidity gestation (Prophylaxis) / calcifications,
Pyrimethamine + chorioretinitis,
Sulfadiazine hydrocephalus
(Treatment)
Rubella IgM+, Low IgG Not routinely None (Prevention Deafness,
Avidity performed via preconception cataracts, PDA,
MMR only) "blueberry muffin"
rash
CMV IgM+, Low IgG >21 weeks & >6 Valacyclovir Periventricular
Avidity weeks 8g/day (2g QID) calcifications,
post-infection sensorineural
hearing loss
HSV Active genital Not routinely C-Section for Vesicular rash,
lesions performed active lesions; temporal lobe
Valacyclovir encephalitis
suppression at 36
wks
Syphilis RPR/VDRL + Fetal ultrasound IM Bicillin L-A Snuffles,
Treponemal (Hydrops/Hepatom (Penicillin G) maculopapular
confirmation egaly) rash,
osteochondritis
Parvovirus B19 IgM+, IgG- MCA Doppler >1.5 Intrauterine blood Severe anemia,
MoM transfusion via nonimmune
cordocentesis hydrops fetalis
PART II: THE ELITE TEST BANK
Questions 1–28: Foundational Syntax & Application
Q1: A 24-year-old at 10 weeks gestation tests positive for primary Cytomegalovirus (CMV).
Which pharmacological intervention is the MOST APPROPRIATE INITIAL action to prevent
vertical transmission? A) Intravenous Ganciclovir. B) CMV Hyperimmune Globulin (HIG) 100
IU/kg. C) Oral Valacyclovir 8g/day. D) Oral Valganciclovir.
● The Answer: C (Oral Valacyclovir 8g/day.)
● Distractor Analysis:
○ A & D are incorrect: Teratogenic; strictly reserved for neonatal or severe adult
, disease.
○ B is incorrect: 2026 ECCI consensus strictly recommends against HIG due to
inefficacy.
The Mentor's Analysis: High-dose Valacyclovir (8g/day) is the 2026 first-trimester paradigm
shift, reducing transmission by 70%. It must be split into 2g QID to prevent acute renal failure.
Professional Intuition: Protect the fetus with the dose; protect the maternal kidneys with the
frequency.
Q2: A neonate born at 38 weeks exhibits chorioretinitis. The mother had a documented
Toxoplasma gondii infection at 22 weeks. Which additional finding is MOST LIKELY present? A)
Periventricular calcifications. B) Diffuse intracranial calcifications. C) Patent ductus arteriosus.
D) Sensorineural hearing loss.
● The Answer: B (Diffuse intracranial calcifications.)
● Distractor Analysis:
○ A is incorrect: Periventricular calcifications are the hallmark of CMV.
○ C & D are incorrect: Classic findings of Congenital Rubella Syndrome.
The Mentor's Analysis: Toxoplasmosis destroys the brain globally, leaving diffuse calcifications
scattered throughout the parenchyma. CMV prefers the ependymal cells, leaving a tight ring
around the ventricles. Professional Intuition: Toxo is scattered; CMV hugs the ventricles.
Q3: Under Texas DSHS 2026 mandates, at which specific gestational juncture is the
third-trimester syphilis screening strictly legally valid? A) At exactly 24 weeks gestation. B) No
earlier than 28 weeks gestation. C) Between 35 and 37 weeks gestation. D) At the onset of
active labor.
● The Answer: B (No earlier than 28 weeks gestation.)
● Distractor Analysis:
○ A is incorrect: Texas law explicitly forbids drawing the third-trimester screen before
28 weeks.
○ C is incorrect: This is the GBS screening window.
○ D is incorrect: Delivery screening is a separate, third mandated test.
The Mentor's Analysis: The 28-week mark is a rigid legal boundary designed to intercept
late-acquired syphilis with enough time (at least 30 days) to treat the mother prior to delivery.
Professional Intuition: Drawing the lab at 27 weeks and 6 days is a critical compliance failure.
Q4: A pregnant patient is exposed to Parvovirus B19. Serology returns: IgG positive, IgM
negative. What is the MOST APPROPRIATE clinical management? A) Initiate serial MCA
Doppler ultrasounds every 2 weeks. B) Administer Varicella-Zoster Immune Globulin (VZIG). C)
Reassure the patient and resume routine prenatal care. D) Schedule an amniocentesis for viral
PCR testing.
● The Answer: C (Reassure the patient and resume routine prenatal care.)
● Distractor Analysis:
○ A & D are incorrect: Invasive or resource-intensive protocols reserved for acute
infections (IgM positive).
○ B is incorrect: VZIG is for Varicella, not Parvovirus.
The Mentor's Analysis: IgG positive with IgM negative indicates remote past exposure and
current absolute immunity. The mother cannot transmit what she cannot catch. Professional
Intuition: Do not chase ghosts. Document immunity and discharge anxiety.
Q5: A G3P2 at 14 weeks gestation presents with acute primary Toxoplasmosis. Which
pharmacological agent is the FIRST-LINE treatment at this gestational age? A) Pyrimethamine.
B) Sulfadiazine. C) Spiramycin. D) Valacyclovir.
● The Answer: C (Spiramycin.)
